400-82-0725
| 规格 | 目录价格 | 上海 | 安徽 | 武汉 | 成都 | 北方 | 深圳 | 会员价格 | 数量 |
|---|---|---|---|---|---|---|---|---|---|
| 00mg | ￥ ǜȖǑLJLJ | > 0 | > 0 | -- | -- | -- | -- | ￥ ǜȖǑLJLJ | - + |
| 250mg | ￥ īũũǑLJLJ | > 0 | > 0 | -- | -- | -- | -- | ￥ īũũǑLJLJ | - + |
| 500mg | ￥ ĽLJLJǑLJLJ | > 0 | > 0 | -- | -- | -- | -- | ￥ ĽLJLJǑLJLJ | - + |
| g | ￥ ƄũLJǑLJLJ | > 0 | > 0 | -- | 5 | 3 | 3 | ￥ ƄũLJǑLJLJ | - + |
| 5g | ￥ īũƄīǑLJLJ | > 0 | > 0 | -- | 2 | 2 | ￥ īũƄīǑLJLJ | - + | |
| 0g | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
| 25g | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
| 00g | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
85.
[]. Weng W, et al. Antibody-Exatecan Conjugates with a Novel Self-immolative Moiety Overcome Resistance in Colon and Lung Cancer. Cancer Discov. 2023 Apr 3;3(4):950-973.
[2]. Zhang Hongwei, et al. Intermediate for synthesizing camptothecin derivatives using exatecan mesylate and its preparation method and application. China, CN470998. 2020-07-3.
H302-H35-H39-H335
P2-P24-P270-P27-P280-P302+P352-P304+P340-P305+P35+P338-P330-P32+P34-P403+P233-P405-P50
09392 现货
￥ ũƑǬLJǑLJLJ -00mg
8959 现货
￥ ƑĽīƑǑLJLJ -00mg
2598 现货
￥ ũīƑLJǑLJLJ -00mg
99780 现货
￥ ƑřřǑLJLJ -00mg
8707 货期咨询
28733 货期咨询
￥ ĽřǬǑLJLJ -00mg
234740 货期咨询
252 货期咨询
23778 货期咨询
￥ ĽƑǑLJLJ -250mg
沪ICP备70945号
